Drug intelligence / Profile preview

Kaixin Ningshen Powder

Development stage: Unknown
Lead developer: Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Administration: Oral

Overview

Kaixin Ningshen Powder is a Traditional Chinese Medicine (TCM) herbal formula developed by the Affiliated Hospital of Shandong University of Traditional Chinese Medicine for the treatment of tic disorders in children. The preparation is designed to alleviate motor and vocal tics by addressing TCM-defined imbalances, specifically focusing on calming the spirit and regulating the mental state. It is currently being evaluated in clinical trials in China, where its efficacy is measured using the Yale Global Tic Severity Scale (YGTSS) and TCM syndrome-based symptom grading scales. The formula typically consists of a combination of multiple botanical ingredients intended to provide a synergistic therapeutic effect.

Other names: Kaixin Ningshen San

Beyond the preview

Go deeper on Kaixin Ningshen Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kaixin Ningshen Powder.

Explore the full profile